Theravance Biopharma shares owned by Citadel Advisors
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theravance Biopharma by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.0M | 316k | 9.41 |
| 2024-09-30 | $1.9M | 236k | 8.06 |
| 2024-06-30 | $2.2M | 261k | 8.48 |
| 2024-03-31 | $1.1M | 120k | 8.97 |
| 2023-12-31 | $1.7M | 155k | 11.24 |
| 2023-09-30 | $377k | 44k | 8.63 |
| 2023-06-30 | $1.0M | 97k | 10.35 |
| 2023-03-31 | $1.1M | 104k | 10.85 |
| 2022-12-31 | $1.9M | 166k | 11.22 |
| 2022-06-30 | $235k | 26k | 9.05 |
| 2022-03-31 | $374k | 39k | 9.65 |
| 2021-12-31 | $462k | 42k | 10.94 |
| 2021-09-30 | $2.5M | 340k | 7.40 |
| 2021-03-31 | $220k | 11k | 20.37 |
| 2020-09-30 | $2.2M | 149k | 14.78 |
| 2020-06-30 | $3.6M | 171k | 20.99 |
| 2020-03-31 | $473k | 21k | 23.13 |
| 2019-12-31 | $766k | 30k | 25.89 |
| 2019-06-30 | $795k | 49k | 16.32 |
| 2019-03-31 | $1.9M | 85k | 22.67 |
| 2018-12-31 | $775k | 30k | 25.59 |
| 2018-09-30 | $910k | 28k | 32.66 |
| 2018-06-30 | $743k | 33k | 22.66 |
| 2017-03-31 | $3.1M | 85k | 36.82 |
| 2015-12-31 | $222k | 14k | 16.40 |
| 2015-03-31 | $662k | 38k | 17.36 |
| 2014-12-31 | $718k | 48k | 14.92 |
| 2014-09-30 | $323k | 14k | 23.07 |
| 2014-06-30 | $1.3M | 40k | 31.88 |